CLDX
NASDAQ
$35.42
Celldex Therapeutics Inc (CLDX)
Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $57.53 (+62.42%)
Market Cap
$2.55B
EPS 5Y CAGR
+21.48%
FCF 5Y CAGR
+36.21%
Free Cash Flow Yield
-8.87%
Price Chart
Valuation
Market Cap$2.55B
P/S3476.34
P/B6.57
Profitability
Total Revenue (TTM)$865K
Gross Profit (TTM)-$265M
EBITDA-$306M
Operating Margin-562900%
EPS-$4.27
Financial Health
Free Cash Flow Yield-8.87%
Growth & Risk
EPS 5Y CAGR+21.48%
Revenue 5Y CAGR-30.61%
FCF 5Y CAGR+36.21%
Beta (5Y)1.17
Sharpe Ratio0.97